{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:11:37Z","timestamp":1771463497656,"version":"3.50.1"},"reference-count":40,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Denver Health and Hospital Authority"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use & Misuse"],"published-print":{"date-parts":[[2025,7,29]]},"DOI":"10.1080\/10826084.2025.2497950","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:16:33Z","timestamp":1746170193000},"page":"1375-1381","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use"],"prefix":"10.1080","volume":"60","author":[{"given":"Corinne L.","family":"Chandler","sequence":"first","affiliation":[{"name":"Department of Health, Human Performance & Recreation, University of Arkansas","place":["Fayetteville, USA"]},{"name":"Center for Public Health and Technology, University of Arkansas","place":["Fayetteville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-7391","authenticated-orcid":false,"given":"Mance E.","family":"Buttram","sequence":"additional","affiliation":[{"name":"Department of Health, Human Performance & Recreation, University of Arkansas","place":["Fayetteville, USA"]},{"name":"Center for Public Health and Technology, University of Arkansas","place":["Fayetteville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University in St. Louis School of Medicine","place":["St. Louis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,5]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-023-01150-1"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107554"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2022.2132506"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305412"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2017.19.3\/tcicero"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00949-3"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000069"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15154"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106729"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.029"},{"issue":"11","key":"e_1_3_3_13_1","first-page":"2619","article-title":"Club drugs: MDMA, Gamma-hydroxybutyrate (GHB), rohypnol, and ketamine","volume":"69","author":"Gahlinger P. M.","year":"2004","unstructured":"Gahlinger, P. M. (2004). Club drugs: MDMA, Gamma-hydroxybutyrate (GHB), rohypnol, and ketamine. American Family Physician, 69(11), 2619\u20132626.","journal-title":"American Family Physician"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0625-0"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106541"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00277"},{"issue":"8","key":"e_1_3_3_17_1","first-page":"625","article-title":"Effects of ketamine on precipitated opiate withdrawal","volume":"42","author":"Jovai\u0161a T.","year":"2006","unstructured":"Jovai\u0161a, T., Laurin\u0117nas, G., Vosylius, S., \u0160ipylait\u0117, J., Badaras, R., & Iva\u0161kevi\u010dius, J. (2006). Effects of ketamine on precipitated opiate withdrawal. Medicina, 42(8), 625\u2013634.","journal-title":"Medicina,"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108976"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1081\/JA-200066936"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.08.015"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106756"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-022-00432-9"},{"key":"e_1_3_3_23_1","volume-title":"Rocky Mountain Poison and Drug Center","author":"McDaniel H. A.","year":"2016","unstructured":"McDaniel, H. A., Severtson, S. G., Bartleson, B. B., Green, J. L., & Dart, R. C. (2016). Comparing prescription opioids, methadone and heroin rates from the Treatment Episode Data Set to the RADARS\u00ae System Treatment Center Programs Combined. RADARS\u00ae System Technical Report, Rocky Mountain Poison and Drug Center."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12263"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.024"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2023.2207716"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221140006"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13259"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306486"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.1423"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5798285"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109551"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22536"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2021.1949612"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.09.003"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107958"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.06.020"},{"key":"e_1_3_3_38_1","unstructured":"U.S. Food and Drug Administration U. S. Drug Enforcement. (2020). Ketamine Drug Fact Sheet. U. S. Department of Justice."},{"key":"e_1_3_3_39_1","unstructured":"U.S. Food and Drug Administration U. S. Food and Drug. (2022). \"FDA alerts health care professionals of potential risks associated with compounded ketamine nasal spray.\" U. S. Food and Drug Administration. Retrieved March 8 2022 from https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-alerts-health-care-professionals-potential-risks-associated-compounded-ketamine-nasal-spray"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102934"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2022.2058896"}],"container-title":["Substance Use & Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2025.2497950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:47:42Z","timestamp":1753433262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2025.2497950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,7,29]]}},"alternative-id":["10.1080\/10826084.2025.2497950"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2025.2497950","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}